Health Care: Drugs

Regulus Therapeutics Inc (RGLS: NASDAQ)

$2.5 n/a | n/a%
12/02/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.50
52 Week High 10.18
52 Week Low 2.13
Avg. Daily Vol. (Mil) 0.42
Beta (3 year) 1.63
Share Related Items
Mkt Cap (Mil) 132.31
Shares Out (Mil) 52.92
Float (Mil) 44.41
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 7.00
Current Ratio 7.80
LT Debt/ Equity 0.27
Total Debt / Equity 0.27
Valuation Ratios
Price Earnings n.a.
Price/Sales 10.99
Price/Book 1.82
Price/Cash Flow -2.00
Per Share Data
Earnings -1.30
Sales 0.23
Book Value 1.37
Cash Flow -1.25
Business Summary
Regulus Therapeutics Inc is a biopharmaceutical company. The Company is engaged in discovering and developing first-in-class drugs that target microRNAs to treat various diseases.
General Information
3545 John Hopkins Court
Suite 210
San Diego, CA 92121
www.regulusrx.com
Industry : Drugs
Sector: Health Care
Employees: 95
CEO: Dr. Paul C. Grint, M.D.
Short Interest
Current Month (Mil) 3.07
Previous Month (Mil) 4.30
Short Interest Ratio (Days) 7.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -59.40
Return on Investments -74.70
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with RGLS

Latest RGLS Headlines from TheStreet

More Financial News for RGLS

Press Releases for RGLS

See All Press Releases

Partner Headlines for RGLS

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter